Expression of luminal (FOXA1, GATA3, PPARG, etc.)and basal (KRT1, KRT5, KRT6A, etc.)[4, 5] genes have been used to molecularly characterize muscle invasive BLCA. The gene discussed is PPARG; the disease is bladder transitional cell carcinoma.